UK woman seeking access to psilocybin therapy wins key human rights court ruling that forces a judicial review of medicine access and end-of-life care

Psilocybin therapy for end-of-life distress is at the center of a UK legal case that secured a significant human rights court victory. A woman seeking legal access to psilocybin treatment won a ruling that compels further judicial scrutiny of how the state handles access to controlled medicines in the context of serious illness and palliative care. The dispute connects psychedelic-assisted therapy with questions of bodily autonomy, dignity, and the rights of patients facing severe suffering. The ruling does not automatically legalize treatment, but it raises the profile of psilocybin within mainstream legal and medical debate and could influence future policy around compassionate access, mental health treatment, and experimental care in the UK. The case matters because it frames psychedelic access not only as a drug policy issue but also as a human rights question. That shift could affect how courts, regulators, and clinicians evaluate psilocybin therapy for people with terminal illness or profound psychological distress.